Toth Cory C, Burak Kelly, Becker Werner
University of Calgary, Neurosciences, Calgary, Alberta, Canada.
Headache. 2005 Mar;45(3):245-6. doi: 10.1111/j.1526-4610.2005.05053_1.x.
We report the case of a female liver transplant recipient who developed a recurrence of severe migraine with aura while on tacrolimus therapy with subsequent remission of headache following discontinuation of tacrolimus and substitution with sirolimus therapy. Headaches in transplant-recipient patients have become a new area of interest for headache specialists. In particular, immunosuppressant medications such as cyclosporine, tacrolimus, sirolimus, and OKT3 have been associated with development of headache syndromes in the transplant patient, exacerbation of previous headaches syndromes, and development of encephalopathies including headache as a clinical feature.
我们报告了一例女性肝移植受者的病例,该患者在接受他克莫司治疗期间出现了伴有先兆的严重偏头痛复发,停用他克莫司并换用西罗莫司治疗后头痛随后缓解。移植受者患者的头痛已成为头痛专家关注的新领域。特别是,免疫抑制剂药物如环孢素、他克莫司、西罗莫司和OKT3与移植患者头痛综合征的发生、既往头痛综合征的加重以及包括以头痛为临床特征的脑病的发生有关。